Additionally, Canopy Growth Has Been A Busy Bee On The Acquisition Front.

As a retailer of cannabis products, Canopy Growth could benefit greatly if Canadian Prime Minister Justin Trudeau moves forward with his pledge to legalize pot. This would nicely complement the company’s impressive year-over-year registered patient growth from approximately 8,000 patients in the third quarter of the previous year to more than 29,000 in Q3 this fiscal year. Image source: Getty Images. Additionally, Canopy Growth has been a busy bee on the acquisition front. Its most important business development was its buyout of Mettrum Health, which was completed at the end of January. This acquisition significantly boosted the company’s growth production capacity. Canopy Growth is also counting on its brand-name products to drive sales. Its best-known brand is Tweed, but it also entered a partnership with well-known rapper Snoop Dogg in medical marijuana videos October 2016. The Leafs by Snoop strains are already being sold by Tweed. To be clear, Canopy Growth is valued at roughly 36 times its extrapolated 12-month sales and about 205 times its 12-month trailing EBITDA, so it’s not cheap by any means.

To read more visit http://www.foxbusiness.com/markets/2017/04/03/these-2-are-only-marijuana-stocks-generating-positive-ebitda.html

Comments are closed.